Freyr Selected to Provide CMC Regulatory Services for a Global Pharma R&D Firm

Riding on its core values of providing highest quality standards and delivery excellence across client engagements, Freyr has added yet another feather to its cap. Following the successful project delivery of an ongoing engagement, Freyr has signed another contract to provide strategic services in the CMC Regulatory Services space for an independent associated company providing Research & Development in three core areas of pain, oncology and respiratory.

Freyr’s CMC Regulatory Affairs consultants have extensive experience interacting with both FDA and EMEA. Freyr will identify critical path activities and timelines to begin work on the project soon. The client has also engaged with Freyr for another project in the EVMPD space which is currently operational.

Presently all resources assigned for both projects are working from the Freyr’s global operations center in India.